SLC35B2
Basic information
Region (hg38): 6:44254095-44257890
Links
Phenotypes
GenCC
Source:
- leukodystrophy, hypomyelinating, 26, with chondrodysplasia (Limited), mode of inheritance: AR
- leukodystrophy, hypomyelinating, 26, with chondrodysplasia (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Leukodystrophy, hypomyelinating, 26, with chondrodysplasia | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 35325049 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (30 variants)
- not provided (3 variants)
- Leukodystrophy, hypomyelinating, 26, with chondrodysplasia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC35B2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 29 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 1 | 0 | 29 | 2 | 2 |
Highest pathogenic variant AF is 0.0000329
Variants in SLC35B2
This is a list of pathogenic ClinVar variants found in the SLC35B2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-44254727-C-G | not specified | Uncertain significance (Aug 17, 2022) | ||
6-44254753-G-A | not specified | Uncertain significance (Mar 04, 2024) | ||
6-44254764-C-G | not specified | Uncertain significance (Sep 01, 2021) | ||
6-44254770-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
6-44254774-C-T | not specified | Uncertain significance (Apr 11, 2023) | ||
6-44254779-ACT-A | Leukodystrophy, hypomyelinating, 26, with chondrodysplasia | Pathogenic (Apr 27, 2023) | ||
6-44254784-GAGC-G | Primary bone dysplasia with multiple joint dislocations • Leukodystrophy, hypomyelinating, 26, with chondrodysplasia | Pathogenic (Feb 28, 2023) | ||
6-44254794-G-C | not specified | Uncertain significance (Feb 10, 2022) | ||
6-44254806-A-G | not specified | Uncertain significance (May 04, 2022) | ||
6-44254888-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
6-44254909-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
6-44254920-A-T | not specified | Uncertain significance (Dec 21, 2023) | ||
6-44254922-C-G | not specified | Uncertain significance (Oct 05, 2021) | ||
6-44254933-T-C | not specified | Uncertain significance (May 05, 2023) | ||
6-44254948-G-T | not specified | Uncertain significance (Jul 12, 2022) | ||
6-44254981-G-C | Benign (Jul 20, 2018) | |||
6-44255007-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
6-44255109-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
6-44255166-G-A | not specified | Uncertain significance (Apr 14, 2022) | ||
6-44255214-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
6-44255220-C-G | not specified | Uncertain significance (Dec 15, 2021) | ||
6-44255221-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
6-44255257-C-T | not specified | Uncertain significance (Jul 17, 2023) | ||
6-44255299-C-T | not specified | Uncertain significance (Sep 28, 2022) | ||
6-44255302-A-G | not specified | Uncertain significance (Feb 06, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC35B2 | protein_coding | protein_coding | ENST00000393812 | 4 | 3459 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0715 | 0.926 | 125701 | 0 | 47 | 125748 | 0.000187 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.261 | 263 | 251 | 1.05 | 0.0000141 | 2748 |
Missense in Polyphen | 72 | 81.672 | 0.88158 | 985 | ||
Synonymous | -2.37 | 137 | 106 | 1.29 | 0.00000574 | 961 |
Loss of Function | 2.66 | 5 | 16.7 | 0.299 | 9.15e-7 | 162 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000173 | 0.000173 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000693 | 0.000693 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the transport of adenosine 3'-phospho 5'- phosphosulfate (PAPS), from cytosol into Golgi. PAPS is a universal sulfuryl donor for sulfation events that take place in the Golgi. May indirectly participate in activation of the NF- kappa-B and MAPK pathways. {ECO:0000269|PubMed:12716889}.;
- Pathway
- Transport and synthesis of PAPS;Metabolism of carbohydrates;Phase II - Conjugation of compounds;Glycosaminoglycan metabolism;Biological oxidations;Metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Cytosolic sulfonation of small molecules;Methionine and cysteine metabolism;Transport of nucleotide sugars
(Consensus)
Intolerance Scores
- loftool
- 0.698
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.77
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.911
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc35b2
- Phenotype
Zebrafish Information Network
- Gene name
- slc35b2
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- organization quality
Gene ontology
- Biological process
- positive regulation of I-kappaB kinase/NF-kappaB signaling;3'-phosphoadenosine 5'-phosphosulfate transport;3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;3'-phospho-5'-adenylyl sulfate transmembrane transport
- Cellular component
- Golgi membrane;Golgi apparatus;membrane;integral component of membrane;integral component of Golgi membrane;integral component of endoplasmic reticulum membrane
- Molecular function
- transmembrane transporter activity;3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity